Oncolytic viruses: past and present
European Pharmaceutical Review
AUGUST 25, 2022
This strategy has failed to gain a foothold in the past as the patient’s immune system interferes, destroying the unprotected oncolytic viruses. 7 Studies also sought to modify oncolytic viruses with additional genes that more efficiently recruit the patient’s immune system to target tumour cells. suppressing activity.
Let's personalize your content